Jacques Zoungrana

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 72 citations

Public Health, Community Health, Pharmacotherapy +17

Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting

Nongodo Firmin Kaboré, Armel Poda, Jacques Zoungrana et al. · BMC Nephrology · 2019 · 45 citations · Full text

Medicine, Nephrology, Hiv Control +16

Dengue infection during pregnancy in Burkina Faso: a cross-sectional study

Kongnimissom Apoline Sondo, Adama Ouattara, Éric Arnaud Diendéré et al. · BMC Infectious Diseases · 2019 · 31 citations · Full text

Medicine, Infectious Diseases, Maternal Health +16

Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase, Plasmid-Mediated Quinolone Resistance, and Carbapenemase-Producing Gram-Negative Bacilli in Burkina Faso

Soufiane Sanou, Abdoul–Salam Ouédraogo, Salim Aberkane et al. · Microbial Drug Resistance · 2020 · 21 citations

Life Sciences, Infectious Diseases, Microbiology +17

Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study

Serge Eholié, Raoul Moh, Delphine Gabillard et al. · The Lancet HIV · 2019 · 19 citations

Public Health, Community Health, Hiv Control +15